lobbying_activities: 2143054

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
2143054	ebf39b3f-bda8-48bb-afdc-761129fa423e	Q2	BROWN RUDNICK LLP	287895	PRIME THERAPEUTICS	2018	second_quarter	PHA	S. 2554-Patient Right to Know Drug Prices Act; H.R. 5343-Prescription Transparency Act of 2018.	HOUSE OF REPRESENTATIVES,SENATE	30000		0	0	2018-07-12T13:30:34.787000-04:00